| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_843659aad9c4fcabeaa8bd2c0728a181 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-00022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10333 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-162 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 |
| filingDate |
2020-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ef71749098f9abb241a683b977cbd92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b7d5a6dc2f3bcfc0e8a8bdf1fedc10c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_857664b5df5ae01e535f6e0c7b027204
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11e3ca902f57e7d5066747eaac80320e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f22753ef8cbfe9b7f29430258d9eb0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32dce37f9470b8db64fcc27daa312653
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bf04f53e51784e51b5f48e10e44ed6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35f09af40a1a69b8a5c83da3ea5871fe |
| publicationDate |
2022-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-11492378-B2 |
| titleOfInvention |
Antibacterial protein EFAL-2 having bacteriolytic ability with respect to Enterococcus faecium |
| abstract |
The present invention relates to an antibacterial protein EFAL-2 derived from bacteriophage Ent-FAP-4 (Accession number: KCTC 12854BP), which has the ability to kill Enterococcus faecium and an amino acid sequence represented by SEQ ID NO: 2, a pharmaceutical composition containing the same as an active ingredient, and a method for preventing or treating diseases caused by Enterococcus faecium using the pharmaceutical composition. |
| priorityDate |
2017-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |